Pharmaceutical Litigation
Accolate®
Manufacturer:
AstraZeneca Pharmaceuticals
Uses: A non-steroidal tablet for the prevention and continuous treatment of asthma in adults
More Information
 |
| Accolate |
Accolate manufacturer AstraZeneca warned that Accolate side effects were potentially deadly. Accolate side effects included severe liver damage. First surfacing in the beginning of 2000, Accolate side effects had been more closely monitored by the FDA. The FDA told AstraZeneca to alert physicians of the dangerous Accolate side effects in September 2000. The company did not send out official FDA warnings regarding Accolate side effects, but instead just sent out physician notices in that month's Physician's Desk Reference.
Side Effects
Hepatotoxicity- Cases of life-threatening hepatic failure have been reported in patients treated with Accolate. Patients should be advised to be alert for signs and symptoms of liver dysfunction (e.g., right upper quadrant abdominal pain, nausea, fatigue, lethargy, pruritus, jaundice, flu-like symptoms, and anorexia) and to contact their physician immediately if they occur. For more information:
Pharmaceutical Litigation
Prescription
Injury FAQs
Pharmaceutical Legal Glossary
|
